Johnson & Johnson

Update in progress

JNJ (NYSE)

Company RatingAt Risk
SectorHealthcare
IndustryDrug Manufacturers - General

Johnson & Johnson and its subsidiaries develop, manufacture, and sell healthcare products worldwide in two segments: Innovative Medicine and MedTech. Innovative Medicine provides prescription therapies across oncology, immunology, neuroscience, infectious diseases, and cardiovascular/metabolic areas, distributed through hospitals, retailers, wholesalers, and clinicians. MedTech offers surgical, orthopedic, cardiovascular, and vision devices, robotics, implants, and eye care products.

Company score

Sentiment: -2.00; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -1.27; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -2.88; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -3.42; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -2.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -2.01; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive